You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 164 No. 6, March 22, 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Review Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (12)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Osteoporosis
 •Women's Health
 •Women's Health, Other
 •Review
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clinical Considerations in Premenopausal Osteoporosis

Margaret L. Gourlay, MD; Sue A. Brown, MD

Arch Intern Med. 2004;164:603-614.

Osteoporosis can occur at any age. In premenopausal osteoporosis, full achievement of peak bone mass may be curtailed, and accelerated bone loss may occur in young adulthood. Premenopausal osteoporosis may be associated with chronic glucocorticoid therapy, prolonged amenorrhea, anorexia nervosa, rheumatoid arthritis, and diseases that affect calcium and vitamin D metabolism. Lesser degrees of bone loss may be associated with common conditions such as dieting, low calcium intake, smoking, and oligomenorrhea. Owing to a paucity of prospective studies on screening and treatment in younger age groups, few practice recommendations exist to guide the management of osteoporosis in young adults. We review the most important clinical concerns in premenopausal osteoporosis, including measurement of bone mass, normal bone accrual, risk factors for premature bone loss, clinical outcomes, and management issues. We emphasize clinically relevant information for primary care physicians, who are usually the first to encounter premenopausal patients with risk factors for early bone loss.


From the Department of Family Medicine, Robert Wood Johnson Clinical Scholars Program (Dr Gourlay), and the Division of Endocrinology, Department of Internal Medicine (Dr Brown), University of North Carolina–Chapel Hill. The authors have no relevant financial interest in this article.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Bone Microarchitecture and Stiffness in Premenopausal Women with Idiopathic Osteoporosis
Cohen et al.
J. Clin. Endocrinol. Metab. 2009;94:4351-4360.
ABSTRACT | FULL TEXT  

Relationship of Obesity with Osteoporosis
Zhao et al.
J. Clin. Endocrinol. Metab. 2007;92:1640-1646.
ABSTRACT | FULL TEXT  

Serum retinyl esters are not elevated in postmenopausal women with and without osteoporosis whose preformed vitamin A intakes are high
Penniston et al.
Am. J. Clin. Nutr. 2006;84:1350-1356.
ABSTRACT | FULL TEXT  

Risk factors for osteoporosis in female patients with systemic lupus erythematosus
Di Munno et al.
Lupus 2004;13:724-730.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.